Second-generation NNRTIs show promising resistance profile, pharmacokinetics in preclinical studies Feb. 8, 1999
AIDS conference serves as forum for highlighting new Vertex/Glaxo Wellcome HIV protease inhibitor Feb. 5, 1999
Promising early clinical results presented this week for ABT-378 in combination with ritonavir Feb. 4, 1999
RSS